Maria Marco

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Venues

Journal of medicinal chemistry

Science translational medicine

Proceedings of the National Academy of Sciences of the United States of America

GlaxoSmithKline Plc

Universidad Complutense de Madrid (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Plc

Spain

Chief Scientist :: Global Health R&D

Education History

Universidad Complutense de Madrid

Spain

BSC :: Chemistry

King's College London

United Kingdom

PHD :: Chemistry

Publications

Stéphanie Braillard, Martine Keenan, Karen J Breese, Jacob Heppell, Michael Abbott, Rafiqul Islam, David M Shackleford, Kasiram Katneni, Elly Crighton, Gong Chen, Rahul Patil, Given Lee, Karen L White, Sandra Carvalho, Richard J Wall, Giulia Chemi, Fabio Zuccotto, Silvia González, Maria Marco, Julianna Deakyne, David Standing, Gino Brunori, Jonathan J Lyon, Pablo Castañeda Casado, Isabel Camino, María Santos Martínez, Bilal Zulfiqar, Vicky Marie Avery, Pim-Bart Feijens, Natascha Van Pelt, An Matheeussen, Sarah Hendrickx, Louis Maes, Guy Caljon, Vanessa Yardley, Susan Wyllie, Susan A Charman, Eric Chatelain
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc 1 . Science translational medicine 15 (726) (2023)
Michael G Thomas, Kate McGonagle, Paul Rowland, David A Robinson, Peter G Dodd, Isabel Camino-Díaz, Lorna Campbell, Juan Cantizani, Pablo Castañeda, Daniel Conn, Peter D Craggs, Darren Edwards, Liam Ferguson, Andrew Fosberry, Laura Frame, Panchali Goswami, Xiao Hu, Justyna Korczynska, Lorna MacLean, J Julio Martin, Nicole Mutter, Maria Osuna-Cabello, Christy Paterson, Imanol Peña, Erika G Pinto, Caterina Pont, Jennifer Riley, Yoko Shishikura, Frederick R C Simeons, Laste Stojanovski, John Thomas, Karolina Wrobel, Robert J Young, Filip Zmuda, Fabio Zuccotto, Kevin D Read, Ian H Gilbert, Maria Marco, Timothy J Miles, Pilar Manzano, Manu De Rycker
Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma cruzi Proteasome Inhibitors. Journal of medicinal chemistry (2023)
Silvia González, Richard J Wall, John Thomas, Stéphanie Braillard, Gino Brunori, Isabel Camino, Juan Cantizani, Sandra Carvalho, Pablo Castañeda Casado, Eric Chatelain, Ignacio Cotillo, Jose M Fiandor, Amanda Fortes Francisco, David Grimsditch, Martine Keenan, John M Kelly, Albane Kessler, Chiara Luise, Jonathan J Lyon, Lorna M MacLean, Maria Marco, J Julio Martin, María Santos Martínez, Christy Paterson, Kevin D Read, Angel Santos-Villarejo, Fabio Zuccotto, Susan Wyllie, Timothy J Miles, Manu De Rycker
Short-course combination treatment for experimental chronic Chagas disease. Science translational medicine 15 (726) (2023)
Michael G Thomas, Stephen Brand, Manu De Rycker, Fabio Zuccotto, Iva Lukac, Peter G Dodd, Eun-Jung Ko, Sujatha Manthri, Kate McGonagle, Maria Osuna-Cabello, Jennifer Riley, Caterina Pont, Frederick Simeons, Laste Stojanovski, John Thomas, Stephen Thompson, Elisabet Viayna, Jose M Fiandor, J Julio Martin, Paul G Wyatt, Timothy J Miles, Kevin D Read, Maria Marco, Ian H Gilbert
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis. Journal of medicinal chemistry 64 (9) (2021)
Michael G Thomas, Manu De Rycker, Richard J Wall, Daniel Spinks, Ola Epemolu, Sujatha Manthri, Suzanne Norval, Maria Osuna-Cabello, Stephen Patterson, Jennifer Riley, Frederick R C Simeons, Laste Stojanovski, John Thomas, Stephen Thompson, Claire Naylor, Jose M Fiandor, Paul G Wyatt, Maria Marco, Susan Wyllie, Kevin D Read, Timothy J Miles, Ian H Gilbert
Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent In Vitro Antileishmanial Activity: Initial SAR and Assessment of In Vivo Activity. Journal of medicinal chemistry 63 (17) (2020)
Susan Wyllie, Stephen Brand, Michael Thomas, Manu De Rycker, Chun-Wa Chung, Imanol Pena, Ryan P Bingham, Juan A Bueren-Calabuig, Juan Cantizani, David Cebrian, Peter D Craggs, Liam Ferguson, Panchali Goswami, Judith Hobrath, Jonathan Howe, Laura Jeacock, Eun-Jung Ko, Justyna Korczynska, Lorna MacLean, Sujatha Manthri, Maria S Martinez, Lydia Mata-Cantero, Sonia Moniz, Andrea Nühs, Maria Osuna-Cabello, Erika Pinto, Jennifer Riley, Sharon Robinson, Paul Rowland, Frederick R C Simeons, Yoko Shishikura, Daniel Spinks, Laste Stojanovski, John Thomas, Stephen Thompson, Elisabet Viayna Gaza, Richard J Wall, Fabio Zuccotto, David Horn, Michael A J Ferguson, Alan H Fairlamb, Jose M Fiandor, Julio Martin, David W Gray, Timothy J Miles, Ian H Gilbert, Kevin D Read, Maria Marco, Paul G Wyatt
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition. Proceedings of the National Academy of Sciences of the United States of America 116 (19) (2019)

Maria Marco.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maria Marco